Facebook Linkedin Twitter
Inside Precision Medicine Researchers Activate Antiviral Immune Pathways in Triple Negative Breast Cancers

Triple-negative breast cancer

Triple negative breast cancer cell undergoing retraction and apoptosis
News & Features

Researchers Activate Antiviral Immune Pathways in Triple Negative Breast Cancers

Malorye Branca -
0
Cancer drug target
Molecular Dx

Potential Precision Therapy for Triple-Negative Breast Cancer Found

Inside Precision Medicine Staff Writer -
0
Translucent image of a woman's torso showing triple negative breast cancer in one breast
News & Features

New Targets For Triple Negative Breast Cancer Therapies Uncovered

Helen Albert -
0
Skin cancer, light micrograph
Molecular Dx

Low Amounts of ctDNA Can Predict Good Immunotherapy Outcome

Helen Albert -
0
Light micrograph of metastases in breast tissue
Molecular Dx

Triple Negative Breast Cancer Recurrence Prediction Method Developed

Chris Anderson -
0
The Breadth of Precision Medicine at ASCO 2019: From early detection to progress in difficult-to-treat cancers and previously undruggable targets
News & Features

The Breadth of Precision Medicine at ASCO 2019: From early detection to progress in difficult-to-treat cancers and previously undruggable targets

[email protected] -
0
General Views Attendees and speakers
Molecular Dx

Foundation Medicine CEO Cindy Perettie’s Top ASCO 2019 Takeaways

Chris Anderson -
0
Metastasis Infection
News & Features

Triple Negative Breast Cancers Activate Resistance Pathway to Evade Chemotherapy

Chris Anderson -
0
Dividing breast cancer cell
News & Features

Triple-Negative Breast Cancer in Mice Inhibited by Migraine and Epilepsy Drug

Inside Precision Medicine Staff Writer -
0
Clinical OMICs Magazine Volume 4, Issue No. 2
News & Features

Clinical OMICs Magazine Volume 4, Issue No. 2

Inside Precision Medicine Staff Writer -
0
1234Page 4 of 4

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine